Evidence for a Lowered Threshold for FDA Approval of Oncologics Based on Single-Arm Phase II Data, Compared to the EMA
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.570
https://www.valueinhealthjournal.com/article/S1098-3015(14)00621-4/fulltext
Section Title :
Cancer
Section Order :
1622
First Page :
A98
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00621-4&doi=10.1016/j.jval.2014.03.570